Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women?
Consideration should be given to re-evaluating azithromycin as the standard treatment for genital chlamydia in women.
These results suggest that, in rings from obese rats, the extract, in addition to increasing the synthesis/release of NO, also inhibits the synthesis/release of a cyclooxygenase-dependent vasoconstrictor metabolite of arachidonic acid, which is increased in obesity.